carbostyril has been researched along with Epilepsy in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, K; Li, G; Li, J; Liu, H; Liu, R; Wang, S; Wang, X; Wei, Y | 1 |
| Garg, A; Jyrwa, S; Sinha, P | 1 |
| Becker, AJ; Ben-Ari, Y; Bordey, A; Buhler, E; Bulteau, C; Burnashev, N; Cardoso, C; Delalande, O; Dorfmuller, G; Dulac, O; Gataullina, S; Goriounova, NA; Lozovaya, N; Milh, M; Minlebaev, M; Pallesi-Pocachard, E; Represa, A; Scavarda, D; Shityakov, S; Tsintsadze, T; Tsintsadze, V; Watrin, F | 1 |
| Campistol, J; Darling, A; Perez-Duenas, B; Poo, P | 1 |
| Tsai, SJ | 1 |
| Abrey, L; Aldape, K; Chang, SM; Cloughesy, TF; DeAngelis, LM; Fink, KL; Gilbert, MR; Groves, MD; Junck, L; Kuhn, J; Lamborn, KR; Lieberman, F; Mehta, M; Prados, MD; Raizer, JJ; Robins, HI; Schiff, D; Wen, PY; Wright, J; Yung, WK | 1 |
| Chai, KY; Jin, YZ; Li, FN; Li, G; Quan, ZS; Sun, XY | 1 |
| Aragona, M | 1 |
| Dalhoff, A; Dimpfel, W; Hofmann, W; Schlüter, G | 1 |
| Kitaura, K; Kuzuhara, S; Miyazaki, M; Takada, T; Tsuda, M; Uda, Y | 1 |
| Wlaź, P | 1 |
| Behl, B; Hofmann, HP; Löscher, W; Potschka, H; Szabo, L; Treiber, HJ; Wlaź, P | 1 |
| Aizenman, E; Gardner, G; Jensen, FE; Orlando, L; Rosenberg, PA; Sanchez, RM; Tauck, DL; Wang, C | 1 |
| De Sarro, A; De Sarro, GB | 1 |
1 review(s) available for carbostyril and Epilepsy
| Article | Year |
|---|---|
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid | 2013 |
1 trial(s) available for carbostyril and Epilepsy
| Article | Year |
|---|---|
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Disease-Free Survival; Drug Administration Schedule; Enzyme Induction; Epilepsy; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; North America; Quinolones; Treatment Outcome | 2006 |
12 other study(ies) available for carbostyril and Epilepsy
| Article | Year |
|---|---|
Synthesis of 3,4-dihydroquinolin-2(1H)-one derivatives with anticonvulsant activity and their binding to the GABA
Topics: Animals; Anticonvulsants; Drug Design; Electroshock; Epilepsy; Mice; Molecular Docking Simulation; Molecular Structure; Pentylenetetrazole; Quinolones; Rats, Wistar; Receptors, GABA-A; Structure-Activity Relationship | 2020 |
Aripiprazole in difficult-to-treat delusional disorder with co-morbid epilepsy.
Topics: Antipsychotic Agents; Aripiprazole; Drug Resistance; Epilepsy; Humans; Male; Piperazines; Quinolones; Schizophrenia, Paranoid; Young Adult | 2014 |
Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.
Topics: Action Potentials; Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Epilepsy; Gene Expression Regulation; Heterozygote; Humans; Male; Mice; Mice, Transgenic; Microtomy; Neocortex; Patch-Clamp Techniques; Pyrazoles; Quinolones; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tissue Culture Techniques; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins | 2014 |
TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism.
Topics: Aripiprazole; Autistic Disorder; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Epilepsy; Humans; Piperazines; Quinolones; Receptor, trkB; Signal Transduction | 2006 |
Synthesis of 8-alkoxy-4,5-dihydro-[1,2,4]triazole[4,3-a]quinoline-1-ones and evaluation of their anticonvulsant properties.
Topics: Animals; Anticonvulsants; Convulsants; Electroshock; Epilepsy; Female; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Pentylenetetrazole; Postural Balance; Quinolones; Spectrophotometry, Infrared; Triazoles | 2006 |
Tolerability and efficacy of aripiprazole in a case of psychotic anorexia nervosa comorbid with epilepsy and chronic renal failure.
Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Aripiprazole; Comorbidity; Epilepsy; Female; Humans; Kidney Failure, Chronic; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome | 2007 |
Electrically evoked potentials in the rat hippocampus slice in the presence of aminophylline alone and in combination with quinolones.
Topics: Aminophylline; Animals; Drug Interactions; Electric Stimulation; Epilepsy; Evoked Potentials; Hippocampus; In Vitro Techniques; Male; Pyramidal Cells; Quinolones; Rats | 1994 |
A study on gamma-aminobutyric acid (GABA) and its analogues by using molecular orbital methods: on epileptogenicity of new quinolones.
Topics: Animals; Brain; Epilepsy; gamma-Aminobutyric Acid; Humans; Molecular Conformation; Molecular Structure; Neural Inhibition; Quinolones; Receptors, GABA; Structure-Activity Relationship | 1993 |
Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Antimetabolites; Avoidance Learning; Binding, Competitive; Brain Chemistry; Cycloserine; Dizocilpine Maleate; Electroshock; Epilepsy; Excitatory Amino Acid Antagonists; Ligands; Male; Mice; Neurotoxins; Quinolones; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1998 |
LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Epilepsy; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Imidazoles; Kindling, Neurologic; Male; Mice; Mice, Inbred Strains; N-Methylaspartate; Quinolones; Quinoxalines; Receptors, AMPA; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Tritium | 1998 |
Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures.
Topics: Animals; Anticonvulsants; Bicuculline; Chemotactic Factors; Convulsants; Dithionitrobenzoic Acid; Epilepsy; Hippocampus; Indicators and Reagents; Long-Term Potentiation; Membrane Potentials; Oxidation-Reduction; Patch-Clamp Techniques; Pentylenetetrazole; Phosphines; PQQ Cofactor; Quinolones; Quinones; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Seizures; Sulfhydryl Reagents | 2000 |
Responsiveness of genetically epilepsy-prone rats to aminophylline-induced seizures and interactions with quinolones.
Topics: Aminophylline; Animals; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Quinolones; Rats; Rats, Inbred Strains | 1991 |